Athymic nude mice with head and neck squamous cell carcinoma patient-derived xenografts (PDX) and gastric adenocarcinoma PDX were treated with tocilizumab, an anti-IL6Rα antibody that inhibits tumor growth in vivo in part by inhibiting the STAT3 and MEK/ERK signaling. The gene discussed is STAT3; the disease is neoplasm.